Reduced levels of C1 esterase inhibitor (C1-INH) may be due to genetic defects in the SERPING1 gene (hereditary angioedema—HAE) or acquired deficiency (acquired angioedema—AAE) often associated with lymphoproliferative disorders. This evidence concerns the gene SERPING1 and acquired angioedema.